Abstract OT2-30-01: Nordictrip, a translational randomized phase-3study exploring the effect of the addition of capecitabine to carboplatinum-based chemotherapy in early “triple negative” breast cancer, ClinicalTrials.gov Identifier: NCT04335669Niklas Loman, Henrik Lindman, Johan Ahlgren et al.|Cancer Research|2022Cited by 0